Abbonarsi

Continuous compression with asynchronous ventilation improves CPR prognosis? A meta-analysis from human and animal studies - 13/01/23

Doi : 10.1016/j.ajem.2022.11.003 
Mengxue Sun a, b, Aiqun Zhu b, c, , Yangyang Tang a, b
a Xiangya Nursing School of Central South University, Changsha, Hunan, China 
b Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China 
c Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China 

Corresponding author at: Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University; Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Renmin Middle Road, No. 139, Changsha, Hunan 410000, China.Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South UniversityDepartment of Emergency MedicineThe Second Xiangya Hospital of Central South UniversityRenmin Middle Road, No. 139ChangshaHunan410000China

Abstract

Background

The cardiopulmonary resuscitation (CPR) compression to ventilation strategy remains controversial. We conducted a meta-analysis to compare the outcomes between continuous chest compressions CPR with asynchronous ventilation (CCC-CPR) and interrupted chest compressions CPR with synchronous ventilation (ICC-CPR) in cardiac arrest.

Methods

PubMed, Web of Science, Embase, MEDLINE (Ovid/LWW) and the Cochrane Libraries were searched up from inception to July 31, 2022. Human and animal studies comparing CCC-CPR versus ICC-CPR were included. Outcome variables were return of spontaneous circulation (ROSC), time to ROSC, survival to discharge, 1-month survival, survival at 4 h, good neurological function, mean arterial pressure (MAP) and other clinical parameters. Jadad Scale and Newcastle-Ottawa Scale were used to assess the study quality and risk of bias.

Results

The systematic search identified eight studies on humans and twelve studies on animal trials. There were no significant differences in ROSC (odd ratios [OR] 1.07; 95% confidence interval [CI]: 0.86–1.32; P = 0.55), survival to hospital discharge (OR 1.04; 95%CI 0.77–1.42; P = 0.79), 1-month survival (OR 1.07; 95%CI 0.84–1.36; P = 0.57), and good neurological outcome (OR 0.92; 95%CI 0.84–1.01, P = 0.09) between CCC-CPR and ICC-CPR in human studies. In animal trials, CCC-CPR had significantly higher rate of ROSC (OR = 1.81; 95% CI: 0.94–3.49; P = 0.07), survival at 4 h (OR 2.57; 95% CI: 1.16–5.72; P = 0.02) and MAP (mean difference [MD] 0.79, 95% CI: 0.04–1.53; P = 0.04), even though no significant differences in ROSC time, arterial potential of hydrogen (pH) and partial tension of carbon dioxide (PaCO2).

Conclusion

CCC-CPR did not show superiority in human outcomes compared with ICC-CPR, but its effect value was significantly increased in animal experiments. We should take the positive outcomes from animals and apply them to human models, and more physiological mechanisms need to be confirmed in CPR patients with different compression-ventilation strategies to improve the prognosis of cardiac arrest.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Cardiopulmonary resuscitation, Cardiac arrest, Continuous chest compression, Interrupted chest compression, Asynchronous ventilation, Synchronous ventilation


Mappa


© 2022  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 64

P. 26-36 - febbraio 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Aerosol containment device design considerations and performance evaluation metrics
  • Rachael M. Jones, Niles Andrus, Thomas Dominguez, Jeremy Biggs, Brian Hansen, Frank A. Drews
| Articolo seguente Articolo seguente
  • Institutional response to the 2022 iodinated contrast shortage: A narrative review
  • Abigail Rosander, Ryan Andrade, Jennifer Concepcion, Lucille Woodley, Will Havron, Adel Elkbuli

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.